G laucoma is one of the main causes of blindness worldwide. 1 Despite the fact that intraocular pressure (IOP) has been unequivocally linked to both the development 2 and progression 3 of the disease, it is still unclear how resistance to outflow of aqueous humor causes the optic neuropathy that leads to blindness. It has been proposed that elevated IOP has direct mechanical or vascular effects on the optic nerve head (ONH) 4 or that it affects retinal physiology in such a way that it ultimately leads to axonal and RGC loss. 5 However, it is hard to prove such effects in humans.
Animal models of glaucoma have been used to study this relationship. In the past decade, mouse models of the disease have been extensively studied. Although mice do not have a formed lamina cribrosa, their ONH has significant similarities to the human ONH. 6 Mouse models offer the potential of using the power of genetics to answer specific questions regarding the pathophysiology of the disease. The spontaneous DBA/2 mouse has emerged as the most widely used model of glaucoma, 7, 8 as it develops a well characterized optic neuropathy with elements that strongly mimic the human disease.
Various investigators have attempted to determine how IOP potentially causes changes in the retina or optic nerve in the DBA/2 mice by investigating gene expression changes that occur in these tissues in response to either high IOP or various amounts of RGC loss. 9 -14 Some of the characteristics of glaucoma in these animals, however, make studies on DBA/2 mice challenging:
1. DBA/2 mice develop cataracts at approximately the time that the optic neuropathy starts, making in vivo quantitative evaluation of the ONH impossible. 2. Glaucomatous damage (as in humans) is variable, even in this inbred mouse strain. Such damage is at times dramatically different even between pairs of eyes of the same animal. Ultimately, a portion of the eyes (ϳ10% for female animals) maintain a normal RGC and axonal count late into life. 3 . Cumulative elevated IOP exposure shows strong association with RGC and axonal loss (as in humans). However, correlation studies (and similar to human glaucoma) have shown that IOP accounts for roughly 50% of the effect observed (JD, unpublished data; see also Refs. 15, 16) . Of course, one can argue that IOP measurements are momentary in nature and that this lack of very high correlation results from the necessary extrapolation from a very limited sample. It is also plausible that some other IOP function (e.g., maximal IOP, IOP fluctuation) may be a better predictor of optic neuropathy. To date, however, no such function has been convincingly identified.
Taking these characteristics into account, we attempted to determine the effects of IOP exposure and various amounts of axonal damage on global retinal gene expression in DBA/2 mice. To achieve that, we used microarrays to analyze independently the effect of IOP elevation and degree of axonal damage. Although similar studies have been performed in the past, 10 this is the first time a genetically more appropriate mouse (i.e., a mouse that is closer genetically to the DBA/2J mouse) has been used as the control, to eliminate age-related changes that may confound these comparisons.
MATERIALS AND METHODS

Animals
DBA/2J, DBA/2J pe , and C57BL/6 mice ranging from 3 to 18 months of age were used. DBA/2 and C57BL/6 animals were obtained from Jackson Laboratories (Bar Harbor, ME) at the appropriate age and kept at the Mount Sinai School of Medicine animal care unit for the duration of the experiment. DBA2J pe mice were obtained from cryopreserved stock at Jackson Laboratories and were used to establish a colony at the Mount Sinai School of Medicine. Animals from this colony were used after appropriate aging. The mice were kept in a 12-hour light/12-hour dark cycle and fed ad libitum. All procedures were performed in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research and were approved by the Institutional Animal Care Committee.
Noninvasive IOP Measurement in Mice
IOP was measured in mice noninvasively on approximately a biweekly basis with a rebound tonometer. 17 The animals were held in a custommade restraint that does not compress the chest or neck while IOP is measured. 18 IOP measurements were performed after application of 0.5% proparacaine topical anesthesia. Five measurements per eye were obtained and averaged. IOP measurements were performed between 10 AM and 12 PM, to minimize the effect of diurnal IOP variation. To determine the effects of IOP on gene expression, the eyes with the upper and lower quartiles of cumulative IOP exposure in the 6-, 9-, and 12-month-old groups of animals were used for RNA extraction for microarray comparison.
Optic Nerve Damage Assessment
In another set of mice, animals were perfused transcardially with 4% paraformaldehyde (PFA) at the time of euthanization and after enucleation (see below). The cranium was opened, and the brain, together with the optic nerves, was removed and immersed in a mixture of 1.2% PFA/0.8% glutaraldehyde for 24 hours at 4°C. The fixative was then washed off, and the optic nerves were osmicated in 2% osmium tetroxide and embedded in epoxy resin (LR White; Electron Microscopy Sciences, Hatfield, PA). Semithin sections were cut with an ultramicrotome, stained with p-phenylenediamine, mounted, and observed under a microscope equipped with a 100ϫ oil-immersion lens. Nerves were graded for the amount of axonal damage semiquantitatively on a three-point scale (none-mild, moderate, or severe) based on the presence of abnormal or disorganized myelin staining by two independent observers. Differences between the two observers were resolved by common review. In cases of disagreement during common review, differences were adjudicated by a third observer. To determine the effects of optic nerve damage on gene expression, retinal RNA from eyes with severe ONH damage were compared with those with none-mild damage in the 9-and 12-month-old animals.
Microarrays
Eyes were removed from animals under deep anesthesia before they were euthanized. The eyes were rinsed in diethyl-pyrocarbonate (DEPC)-treated water and placed in RNA stabilizer (RNAlater; Ambion/ Invitrogen, Carlsbad CA). Dissection of the retina was immediately performed in the stabilizer on ice. Retinas were homogenized, and total RNA was extracted (TRIzol reagent; Gibco/Invitrogen, Carlsbad CA). RNA was further purified on RNeasy spin columns (Qiagen, Valencia, CA) and subsequent lithium chloride precipitation. Typical yields were 50 to 80 g RNA from 16 to 20 mg of tissue (ϳ1-2 g per retina). RNA concentrations were determined with a spectrophotometer (Nanodrop; Thermo Scientific, Wilmington, DE) and the 260/ 280-nm absorbance ratio calculated to determine RNA purity. Before array hybridization RNA quality was verified using agarose gel electrophoresis and bioanalysis (Bioanalyzer; Agilent Technologies, Santa Clara, CA). Linear amplification, cRNA synthesis, and hybridization to mouse oligonucleotide arrays (GeneChip mouse genome 430_2.0; Affymetrix, Santa Clara, CA) was performed at the Mount Sinai core microarray facility. Signal intensities for approximately 45,000 probe sets (each probe set consists of 11 perfect matches and 11 mismatches) were obtained from each array. Data quality was verified by inspection of various plots of the probe signal intensities, such as histograms, box plots, and RNA degradation plots, as well as different Affymetrix quality metrics such as the percentage of probe sets that are called "present" by the MAS 5.0 algorithm, 19 the average background, the scale factor, and the GAPDH and ␤-actin 3Ј:5Ј ratios. Arrays failing quality control were replaced with additional arrays.
Probe intensities were processed using the GeneChip Robust Multiarray Average (gcrma) 20 package of Bioconductor. 21 The gcrma package adjusts for background intensities in Affymetrix microarray array data, which include optical noise and nonspecific binding, and converts background-adjusted probe intensities to expression measures after normalization. The summarized data are thus normalized signal intensities that are logarithm base 2 (log 2 ) transformed. These summarized data were subjected to statistical analysis, as described below.
Statistical and Bioinformatics Analysis
To correlate gene expression changes with the degree of ON damage (and account for age), microarray assays were set up as in Table 1 .
Similarly, to correlate gene expression, changes with the degree of exposure to IOP (and account for age), microarray assays were set up as in Table 2 .
Several statistical analyses were performed for both of these two datasets:
1. We identified genes that are differentially expressed at 9 months between DBA/2 mice with different amounts of optic nerve damage (none-mild versus severe) and between DBA/2 mice with different (low versus high) IOP exposure. Similarly, we identified genes that are differentially expressed between the same groups at 12 months of age. We also identified genes differentially expressed at 6 months of age in eyes with different (high versus low) IOP exposure. The computation is performed by using the Bioconductor Limma package. 22 For gene j, the comparison is based on a moderated t-statistic,
Here, x j , y j are, respectively, the average log 2 signal intensities from the gcrma package for the two groups, and s j 2 is the posterior value for the residual SD for the gene j. The empiric Bayes method in the Limma package 22 gives The number in parentheses is the number of mouse eyes analyzed.
, where the prior d 0 ,s 0 2 are estimated from the data of all genes. The moderated t-statistic has the advantage that it does not become extremely large just due to an extremely small sample residual variance s j 2 . The genes are selected by the following criteria: The P value associated with the moderated t-statistic is no greater than 0.05, the maximum group average log 2 signal intensity is no less than 5 and the log 2 signal change ͑x Ϫ y ͒ is no less than 0.5 in absolute value. 2. We identified genes that are associated with optic neuropathy by comparing gene expression in DBA/2 animals with that in the control strains (C57BL/6 and pearl). A two-way ANOVA model with mouse strain and age as factors was used in the Bioconductor Limma package. Gene selection was performed based on the following criteria: a. The maximal group average log 2 signal intensity is no less than 5. b. The P values in comparing pearl and C57BL/6 mice (the two "control" strains) at 3, 6, 9, and 12 months should be no more than 0.05 and the corresponding log 2 -fold change should be less than 2, as we expect both mouse strains to have gene expression that is similarly changing (if at all) as a result of age only. c. The P values associated with moderated t-statistics in comparing the Pearl and DBA/2 mice at both 3 and 6 months should be no more than 0.05, and the corresponding log 2 -fold change should be less than 2, as we expect DBA/2 mice before the onset of axonal loss to have gene expression similar to that of pearl mice. d. The background subtracted log 2 -fold change (defined as the maximum of log 2 -fold changes at 9 and 12 months of DBA/2 severe optic neuropathy relative to Pearl, subtracted by the average log 2 -fold at the comparison in [c]) should be at least 0.5, and its corresponding P value for the moderated t-statistic should be less than 0.01 and the false-discovery rate no larger than 0.05.
For the genes that are associated with IOP exposure, the comparison in (c) is only on 3-month-old mice, and the computation in (d) considers the maximum of the log 2 -fold changes at 6, 9, and 12 months of DBA/2 high IOP exposures relative to pearl after the subtraction of log 2 -fold at the 3 months between DBA/2 and pearl. Genes selected using these procedures were subjected to bioinformatics analysis using pathway analysis software (Ingenuity Systems, Redwood City, CA) to determine functional gene networks and canonical groups whose expression is differentially affected. To find out whether the lists of genes that are differentially expressed in the process of neurodegeneration and prolonged IOP elevation share some specific transcription factors through activation or repression, we used the transcription factor targets (tft) dataset in MSigDB ver 3.0 from the Broad Institute (www.broadinstitute.org, Cambridge, MA) and performed hypergeometric tests to identify transcription factors that are significantly overrepresented in the two gene lists.
Real-Time Polymerase Chain Reaction
cDNA was synthesized using random primers and a reverse transcription kit (Quantitect; Qiagen), per the manufacturer's instructions. cDNA was subjected to RT-PCR (QuantiTect SYBR Green RT-PCR Kit; Qiagen) with specific primer sets (SuperArray Biosciences, Frederick MD). The samples were analyzed at the Mount Sinai School of Medicine RT-PCR core facility.
The rps11 gene (encoding for a ribosomal protein) was used as an internal control for each sample for normalization purposes.
RESULTS
Cumulative IOP exposure was used to determine the effects of IOP on gene expression, as shown in Figure 1 . To improve statistical comparisons, only eyes in the upper and lower quartiles of IOP exposure of the 6-, 9-and 12-month-old animals were used for microarray analysis to study the effect of IOP. Cumulative IOP exposure was significantly different between the high and low IOP exposure groups at all three time points (P Ͻ 0.005, 0.0009, and 0.006 for 6, 9, and 12 months, respectively; t-test).
ON damage was minimal in the 3-and 6-month-old animals ( Fig. 2) . Despite the fact that the damage was graded on a three-point scale the majority (25/28) of the eyes of 9-monthold animals showed either none-mild or severe damage. Thus only these two comparison groups were used in the microarray experiments. At the 12-month age point there were enough eyes with moderate ON damage to allow for inclusion of that group in the analysis as a separate group (Fig. 2) .
Gene Expression Correlated with ON Damage in DBA/2 Mice
In 9-month-old animals with severe ON damage, 240 genes were detected as upregulated and 395 as downregulated when compared with that in similarly aged animals with none-mild ON damage. For 12-month-old animals, the respective numbers were 321 genes and 756 genes. The 10 genes with the largest change in expression (in both directions) are presented in Tables 3 and 4 for the 9-and 12-month-old animals, respectively (full lists are available in the Supplementary Data, http:// Number in parentheses is the number of mouse eyes analyzed.
FIGURE 1.
Cumulative IOP exposure of the DBA/2 eyes used in microarray analysis (three eyes per group). These eyes represent eyes in the higher and lower quartiles of the cumulative IOP distribution at each age group. All eyes included in the analysis were from different animals.
www.iovs.org/lookup/suppl/doi:10.1167/iovs.10-7063/-/DC Supplemental).
Gene Expression Correlated with Cumulative IOP Exposure in DBA/2 Mice
Similarly, in 9-month-old animals with high IOP exposure, 144 genes were detected as upregulated and 58 as downregulated when compared with animals with low IOP exposure. For 12-month-old animals, the respective numbers were 26 and 39 genes. The 10 genes with the largest change in expression (in both directions) are presented in Tables 5 and 6 for the 9-and 12-month-old animals, respectively (full lists are available in the Supplementary Data, http://www.iovs.org/lookup/suppl/doi: 10.1167/iovs.10-7063/-/DCSupplemental).
Gene Expression of DBA/2 Mice with ON Damage Compared with Control Mice (C57BL/6 and Pearl)
When comparing gene expression of DBA/2 mice with various amounts of ON damage with that in C57BL/6 and pearl mice and using the above-described criteria (see the Methods sec-FIGURE 2. Amount of ON damage in DBA/2 animals studied in the various age groups. Three eyes in each group were selected for microarray analysis. All eyes included in the analysis were from different animals. When contralateral eyes had different degrees of ON damage, only the most severely affected eye from that animal was included in the analysis. Finally the top molecular networks and cellular functional groups for the genes associated with both severe ON damage as well as high IOP exposure were Cellular Assembly and Organization (35 genes), Gene Expression (7 genes), Cellular Function and Maintenance (12 genes), Cell Morphology (16 genes), and Molecular Transport (24 genes). The top canonical pathways involved were Pentose Phosphate (3/ 89 genes) and Tumoricidal Function of Hepatic Natural Killer Cells (2/24 genes).
Since genes that change early in the disease process are more likely to be involved in the pathogenesis of the disease, we also subjected to bioinformatic analysis the genes with differential expression in 6-month-old DBA/2J eyes with high versus low IOP. Of the 94 IDs changing, 83 could be mapped to genes. Only four of these (atad2b, dock3, aatk, and gjb6) were network eligible.
The genes that are differentially expressed in the process of neurodegeneration and prolonged IOP elevation can be the result of activation (or repression) of specific transcription factors. We performed hypergeometric tests to identify such transcription factors that are significantly overrepresented in the gene list. Of the 614 in the transcription factor targets (tft) dataset in MSigDB (ver. 3.0), 16 and 15 transcription factors respectively were significantly overrepresented (P Ͻ 0.01) for the differentially expressed genes in retinas either exposed to high IOP or having severe ON damage.
When compiling the data from all microarray studies, we identified several complement genes with altered expression at some time point during glaucomatous pathology development or that are associated with elevated IOP. These genes are shaded in Figure 3 . Since some of these gene changes are biphasic, they are presented as changes without direction.
DISCUSSION
DBA/2 mice are a valuable rodent glaucoma model. The glaucoma-like neurodegeneration that develops resembles human pathology in many respects. Specifically, it appears that it is the result of a period of elevated IOP, it develops (at least initially) in a localized pattern, and there is a large interanimal and intereye variability. 8 Since the pathology localizes in the retinal ganglion cell and its axon, we reasoned that changes within the retina and ON would be preceded (or at least accompanied) by changes in gene expression within these cells as well as cells within the retina that interact either directly or indirectly with the RGCs. We decided to use microarrays to study gene expression, because it makes no a priori assumptions about which genes are changing. Although microarray data are undoubtedly "noisy" because of the very large number of genes concurrently analyzed, 23, 24 it has been successfully used to identify novel pathways that are operational in a variety of conditions. One of the strategies to minimize the inherent noise in microarray analysis would be to select a pure cellular population to study (in this case most probably the RGCs). Although such a strategy has been used in the past, 25 it does make the assumption that all relevant gene changes are happening in the RGCs only. Focusing on gene and protein expression only in RGCs (using for example cell cultures or laser capture microdissection) may result in missing key genes involved in the development or progression of glaucoma. On the other hand, because of the increased sensitivity when analyzing a pure cell population, it can admittedly identify a larger number of genes with expression changing in RGCs. 26 Given the current state of our understanding of glaucomatous retinal pathology, studying total retinal gene expression has specific advantages. Such a strategy makes no assumptions about which other cells (e.g., Müller cells, astrocytes, amacrine cells) may be contributing to the development of glaucoma. In fact, preliminary evidence from both our laboratory 27 as well as other laboratories 28, 29 indicate that the sequence of events leading to RGC death may originate or depend on other cells in the retina.
An approach similar to the one we used in this study has been reported. 10 Our data supplement and expand the results of that study. Specifically, MA analysis of the DBA/2 retina had only been performed on groups of animals up to 8 months of age, an age when DBA animals develop early to moderate damage. 30 By extending our experiments to 12 months, we attempt to identify gene expression changes that occur as a result of or contribute to more advanced damage. Although direct comparison with published studies is not possible because of differences in design, methodology, and analysis, it is interesting to note that we were able to identify a much larger number of genes with changing expression, while confirming some of the genes identified in earlier studies. Despite identi- fication of a larger number of relevant genes, the asynchronous RGC and axonal loss that occurs in the DBA/2 mice and the uncertain timing of pathology in individual animals makes understanding the temporal sequence of gene expression changes difficult. Nevertheless, publication of the full dataset of gene expression changes identified in this study will allow other investigators to compare their gene(s) of interest across studies and, with the help of other publicly available datasets, will enhance our understanding of glaucoma pathophysiology. Our approach is also novel, in that we use two control strains. Traditionally, the C57BL/6 animals have been used as a control for DBA/2 experiments (see also the recommendation by Jackson Laboratories 31 ). However, it has become apparent that the genetic background plays an important role in the development of glaucomatous pathology. The pathogenic mutations in Tyrp1 and Gpnmb that cause glaucoma in DBA/2 mice 32 are not sufficient to cause the full spectrum of pathology in C57BL/6 mice. 33 We used the DBA/2 pe (pearl) strain as an additional control strain. Pearl mice carry the two pathogenic mutations and are on the DBA/2 background. However, because of an additional mutation in the Ap3b1 gene, 34,35 they do not develop the ocular pathology associated with DBA/2 mice. 32 Inclusion of pearl mice as controls allows better differentiation of strain-specific changes in gene expression and allows focusing on pathology relevant genes. Since the design and initiation of these experiments an additional control has become available (the DBA/2 gpnmb wt). 33 Inclusion of this additional control would be ideal, but it was not available to us at the time that this study was performed.
The experimental design takes into account the three factors that can potentially affect gene expression: age, IOP exposure, and axonal loss. Age as discussed above is controlled by comparing DBA/2 mice with the two control strains. For IOP, we elected to compare the eyes with the highest 25% exposure to eyes with the lowest 25% cumulative IOP exposure within our cohort. We measured IOP noninvasively with rebound tonometry, and averaged the results over time to determine total IOP exposure. Cumulative IOP exposure is more appropriate in long-term experiments and has been correlated with IOP damage in other experimental models. 36 Despite the significant variability in IOP over the length of the experiment, we were surprised to see that eyes could clearly be categorized to distinct groups in terms of cumulative IOP exposure. These groups appear to have differential gene expression as early as 6 months of age, a time when ON damage is not yet detectable by the methods used.
The effect of ON damage was independently determined by comparing eyes with severe axonal damage with eyes with none-mild axonal damage at each particular age. Axonal damage was used as a surrogate of RGC loss, since retinas were used for gene expression instead of determining RGC loss directly. During the course of this study, DBA/2 animals expressing the GFP protein under a Thy1 promoter in their RGCs has been reported. 37 Use of these animals may allow a direct assessment of the number of RGCs (and thus of retinal damage). However, the use of ON axonal damage to grade glaucomatous pathology is also appropriate, as axons seem to degenerate slightly before but in close temporal proximity to when RGCs are lost. 38, 39 We have previously reported on the regional gene expression changes within the retina of 11-to 13-month-old DBA/2 animals with focal RGC loss.
14 These differences in gene expression between areas of focal loss and relative RGC preservation involve genes that code for proteins with diverse cellular functions. The current experiments expand on that study by providing a temporal aspect to gene expression changes related to RGC loss and especially by looking at earlier time points during the development of the degeneration.
Because IOP is one of the major factors responsible for axonal and RGC loss in glaucoma it is not surprising that there is considerable overlap of genes with expression affected by both high IOP exposure and ON damage. These genes probably contain the pathways that are responsible for RGC loss as a result of IOP elevation. Conversely, genes identified exclusively in the high-IOP exposure group of eyes are probably related to changes in retinal pathophysiology that do not necessarily contribute directly to RGC loss. Similarly, genes identified exclusively in the group of eyes with severe ON damage are probably secondary changes that occur in the retina as a result of the development of glaucomatous pathology (which includes RGC loss). Some of these changes in gene expression may be responsible for what has been termed "secondary degeneration" in glaucoma. 40 The number of genes affected by cumulative IOP exposure increased as the DBA/2J mice aged from 6 to 9 months. It thus appears that IOP exposure triggers secondary changes in gene expression that increase progressively with time and are further compounded by RGC loss that begins to occur after the eighth month of age. As more and more of the DBA/2J eyes develop significant RGC loss, the effect of IOP exposure decreases in terms of differences in gene expression and the number of genes detected decreases from 9 to 12 months of age. Conversely, the number of genes affected in DBA/2J mice that are associated with ON damage increases with age from 9 to 12 months. Thus, it appears that age-related changes compound the effect caused by ON damage on gene expression.
Detailed examination of the small number of genes with differential expression because of different cumulative IOP exposure at the 6-month time point (when no significant RGC loss can be detected) may provide important clues as to the initial response of the retina to elevated IOP. However, most of the genes affected do not map to well-characterized gene networks. This prompted us to identify transcription factors that regulate genes that are overrepresented in our gene sets. This and other bioinformatic analyses of the genes identified is important, as genes act together in networks. The extent that some of these gene networks are affected illustrates their involvement rather than that they are pathogenetic. In a complex tissue like the retina, it is also probable that different gene networks are changing within different cellular populations. Follow-up studies using in situ hybridization and immunohistochemistry are necessary to better begin to understand how specific genes in specific cell populations lead to pathologic changes in glaucoma.
We decided to further explore the role of complement in glaucomatous pathophysiology by determining which of the genes among the 35 or so that make up this complex system change in expression. Rather than label genes as up-or downregulated, we elected to report them as changing. This method of reporting better reflects the experimental design, as changes in some of the genes are not necessarily monotonic (for example an RGC specific gene that is involved in the disease development may go up early in the disease process, leading to RGC loss, which as a result will decrease its expression within the retina). In fact, a significant number of all the genes identified by microarray analysis do not display monotonic behavior with time. With this in mind, it appears that genes in the classic activation pathway of complement as well as C3 activation (which can participate in both the classic and alternative pathways) are clearly affected in the DBA/2 mice. Not surprisingly, genes involved in the membrane attack complex (MAC) are not affected, despite previous reports in other induced glaucoma models that MAC may lead to RGC loss. DBA/2 mice are C5 deficient and cannot thus form MAC. 41 Whether complement upregulation (and probable activation) plays a protective or destructive role in the disease process is still an open question. 42 It is interesting to note that in human glaucoma (and using a somewhat similar bioinformatic approach) the same genes appear to be involved. 43 In summary, this study provides a comprehensive survey of gene expression in the DBA/2 mice and explores in depth the effects of age, IOP exposure, and axonal damage on this expression. This wealth of data is provided to other investigators in an effort to improve our collective understanding of the basic mechanisms underlying this potentially blinding disease.
